The main aim of the study is to determine the quality of life with the assessment of haemoglobin levels in the chronic kidney disease patients. To assess the quality of life in patients with chronic kidney disease. This study which includes prospective interventional monitoring of ckd patients undergoing the dialysis were carried out for a period of 6 months on both in-patient and out-patients. Anova was used to examine the relationship between Quality of life scores and Heamoglobin level. A total of 178 patients were screened. 126 (71%) were males and 52 (29%) were females. In the age of 41-50 years 48(27%). In the age of 20-30 years 15(8%), 31-40 years 41(23%), 41-50 years 48(27%). 51-60 years 44(25%). 61-70 years 27(15%), 7180 years 3(2%) were found. In this family history of CKD 26(15%), no family history of CKD 152(85%), were found. In this causes don't know 6(4%), DM 12(7%), HTN with DM 10(6%), HTN 123(69%), polycyst 6(4%), pain killer 20(11%) were found. hemodialysis 176(99%), peritoneal dialysis 2(1%). were found. In this 13(7%) of patients has sexual activity, 165(93%) of patients has not sexual activity were found. In this study due to erythropoietin administration in CKD patients hemoglobin levels has increased which shows improvement in the quality of life. Improved physical and mental status of the patients signifies the changes in their life which can helpful in prolonging their life span.